Global Receptor Tyrosine Protein Kinase ERBB 4 Market Research Report 2023

Report ID: 1969794 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Receptor Tyrosine Protein Kinase ERBB 4 Market Overview
    1.1 Product Overview and Scope of Receptor Tyrosine Protein Kinase ERBB 4
    1.2 Receptor Tyrosine Protein Kinase ERBB 4 Segment by Type
        1.2.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 PB-357
        1.2.3 NT-113
        1.2.4 NRG-4
        1.2.5 MIN-301
        1.2.6 Others
    1.3 Receptor Tyrosine Protein Kinase ERBB 4 Segment by Application
        1.3.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Comparison by Application: (2022-2028)
        1.3.2 Skin Cancer
        1.3.3 Systolic Heart Failure
        1.3.4 Neuroblastoma
        1.3.5 Oligodendroglioma
        1.3.6 Others
    1.4 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size Estimates and Forecasts
        1.4.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue 2017-2028
        1.4.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales 2017-2028
        1.4.3 Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Region: 2017 Versus 2021 Versus 2028
2 Receptor Tyrosine Protein Kinase ERBB 4 Market Competition by Manufacturers
    2.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Receptor Tyrosine Protein Kinase ERBB 4 Manufacturing Sites, Area Served, Product Type
    2.5 Receptor Tyrosine Protein Kinase ERBB 4 Market Competitive Situation and Trends
        2.5.1 Receptor Tyrosine Protein Kinase ERBB 4 Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Receptor Tyrosine Protein Kinase ERBB 4 Players Market Share by Revenue
        2.5.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Receptor Tyrosine Protein Kinase ERBB 4 Retrospective Market Scenario by Region
    3.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Receptor Tyrosine Protein Kinase ERBB 4 Market Facts & Figures by Country
        3.3.1 North America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country
        3.3.2 North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Receptor Tyrosine Protein Kinase ERBB 4 Market Facts & Figures by Country
        3.4.1 Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country
        3.4.2 Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Market Facts & Figures by Region
        3.5.1 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Sales by Region
        3.5.2 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Receptor Tyrosine Protein Kinase ERBB 4 Market Facts & Figures by Country
        3.6.1 Latin America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country
        3.6.2 Latin America Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Market Facts & Figures by Country
        3.7.1 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country
        3.7.2 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Receptor Tyrosine Protein Kinase ERBB 4 Historic Market Analysis by Type
    4.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type (2017-2022)
    4.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Type (2017-2022)
    4.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Price by Type (2017-2022)
5 Global Receptor Tyrosine Protein Kinase ERBB 4 Historic Market Analysis by Application
    5.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application (2017-2022)
    5.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Application (2017-2022)
    5.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Aslan Pharmaceuticals Pte Ltd
        6.1.1 Aslan Pharmaceuticals Pte Ltd Corporation Information
        6.1.2 Aslan Pharmaceuticals Pte Ltd Description and Business Overview
        6.1.3 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
        6.1.5 Aslan Pharmaceuticals Pte Ltd Recent Developments/Updates
    6.2 Boehringer Ingelheim GmbH
        6.2.1 Boehringer Ingelheim GmbH Corporation Information
        6.2.2 Boehringer Ingelheim GmbH Description and Business Overview
        6.2.3 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
        6.2.5 Boehringer Ingelheim GmbH Recent Developments/Updates
    6.3 GamaMabs Pharma SA
        6.3.1 GamaMabs Pharma SA Corporation Information
        6.3.2 GamaMabs Pharma SA Description and Business Overview
        6.3.3 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
        6.3.5 GamaMabs Pharma SA Recent Developments/Updates
    6.4 Hanmi Pharmaceuticals Co Ltd
        6.4.1 Hanmi Pharmaceuticals Co Ltd Corporation Information
        6.4.2 Hanmi Pharmaceuticals Co Ltd Description and Business Overview
        6.4.3 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
        6.4.5 Hanmi Pharmaceuticals Co Ltd Recent Developments/Updates
    6.5 Jiangsu Kanion Pharmaceutical Co Ltd
        6.5.1 Jiangsu Kanion Pharmaceutical Co Ltd Corporation Information
        6.5.2 Jiangsu Kanion Pharmaceutical Co Ltd Description and Business Overview
        6.5.3 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
        6.5.5 Jiangsu Kanion Pharmaceutical Co Ltd Recent Developments/Updates
    6.6 Minerva Neurosciences Inc
        6.6.1 Minerva Neurosciences Inc Corporation Information
        6.6.2 Minerva Neurosciences Inc Description and Business Overview
        6.6.3 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
        6.6.5 Minerva Neurosciences Inc Recent Developments/Updates
    6.7 Pfizer Inc
        6.6.1 Pfizer Inc Corporation Information
        6.6.2 Pfizer Inc Description and Business Overview
        6.6.3 Pfizer Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Pfizer Inc Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
        6.7.5 Pfizer Inc Recent Developments/Updates
    6.8 Puma Biotechnology Inc
        6.8.1 Puma Biotechnology Inc Corporation Information
        6.8.2 Puma Biotechnology Inc Description and Business Overview
        6.8.3 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
        6.8.5 Puma Biotechnology Inc Recent Developments/Updates
    6.9 Shanghai Fosun Pharmaceutical (Group) Co Ltd
        6.9.1 Shanghai Fosun Pharmaceutical (Group) Co Ltd Corporation Information
        6.9.2 Shanghai Fosun Pharmaceutical (Group) Co Ltd Description and Business Overview
        6.9.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
        6.9.5 Shanghai Fosun Pharmaceutical (Group) Co Ltd Recent Developments/Updates
    6.10 XuanZhu Pharma Co Ltd
        6.10.1 XuanZhu Pharma Co Ltd Corporation Information
        6.10.2 XuanZhu Pharma Co Ltd Description and Business Overview
        6.10.3 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
        6.10.5 XuanZhu Pharma Co Ltd Recent Developments/Updates
    6.11 Zensun (Shanghai) Sci & Tech Co Ltd
        6.11.1 Zensun (Shanghai) Sci & Tech Co Ltd Corporation Information
        6.11.2 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Description and Business Overview
        6.11.3 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
        6.11.5 Zensun (Shanghai) Sci & Tech Co Ltd Recent Developments/Updates
7 Receptor Tyrosine Protein Kinase ERBB 4 Manufacturing Cost Analysis
    7.1 Receptor Tyrosine Protein Kinase ERBB 4 Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase ERBB 4
    7.4 Receptor Tyrosine Protein Kinase ERBB 4 Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Receptor Tyrosine Protein Kinase ERBB 4 Distributors List
    8.3 Receptor Tyrosine Protein Kinase ERBB 4 Customers
9 Receptor Tyrosine Protein Kinase ERBB 4 Market Dynamics
    9.1 Receptor Tyrosine Protein Kinase ERBB 4 Industry Trends
    9.2 Receptor Tyrosine Protein Kinase ERBB 4 Market Drivers
    9.3 Receptor Tyrosine Protein Kinase ERBB 4 Market Challenges
    9.4 Receptor Tyrosine Protein Kinase ERBB 4 Market Restraints
10 Global Market Forecast
    10.1 Receptor Tyrosine Protein Kinase ERBB 4 Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Receptor Tyrosine Protein Kinase ERBB 4 by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Receptor Tyrosine Protein Kinase ERBB 4 by Type (2023-2028)
    10.2 Receptor Tyrosine Protein Kinase ERBB 4 Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Receptor Tyrosine Protein Kinase ERBB 4 by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Receptor Tyrosine Protein Kinase ERBB 4 by Application (2023-2028)
    10.3 Receptor Tyrosine Protein Kinase ERBB 4 Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Receptor Tyrosine Protein Kinase ERBB 4 by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Receptor Tyrosine Protein Kinase ERBB 4 by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
    Table 2. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
    Table 3. Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Receptor Tyrosine Protein Kinase ERBB 4 Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs) of Key Manufacturers (2017-2022)
    Table 6. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Receptor Tyrosine Protein Kinase ERBB 4 Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Receptor Tyrosine Protein Kinase ERBB 4 Manufacturing Sites and Area Served
    Table 11. Manufacturers Receptor Tyrosine Protein Kinase ERBB 4 Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Receptor Tyrosine Protein Kinase ERBB 4 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Receptor Tyrosine Protein Kinase ERBB 4 as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Region (2017-2022) & (K Pcs)
    Table 16. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Region (2017-2022)
    Table 17. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Region (2017-2022)
    Table 19. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2017-2022) & (K Pcs)
    Table 20. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country (2017-2022)
    Table 21. North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country (2017-2022)
    Table 23. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2017-2022) & (K Pcs)
    Table 24. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country (2017-2022)
    Table 25. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Sales by Region (2017-2022) & (K Pcs)
    Table 28. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2017-2022) & (K Pcs)
    Table 32. Latin America Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country (2017-2022)
    Table 33. Latin America Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2017-2022) & (K Pcs)
    Table 36. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country (2017-2022)
    Table 39. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2017-2022) & (K Pcs)
    Table 40. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type (2017-2022)
    Table 41. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Type (2017-2022)
    Table 43. Global Receptor Tyrosine Protein Kinase ERBB 4 Price by Type (2017-2022) & (USD/Pcs)
    Table 44. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs) by Application (2017-2022)
    Table 45. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application (2017-2022)
    Table 46. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Application (2017-2022)
    Table 48. Global Receptor Tyrosine Protein Kinase ERBB 4 Price by Application (2017-2022) & (USD/Pcs)
    Table 49. Aslan Pharmaceuticals Pte Ltd Corporation Information
    Table 50. Aslan Pharmaceuticals Pte Ltd Description and Business Overview
    Table 51. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 52. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product
    Table 53. Aslan Pharmaceuticals Pte Ltd Recent Developments/Updates
    Table 54. Boehringer Ingelheim GmbH Corporation Information
    Table 55. Boehringer Ingelheim GmbH Description and Business Overview
    Table 56. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 57. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase ERBB 4 Product
    Table 58. Boehringer Ingelheim GmbH Recent Developments/Updates
    Table 59. GamaMabs Pharma SA Corporation Information
    Table 60. GamaMabs Pharma SA Description and Business Overview
    Table 61. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 62. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase ERBB 4 Product
    Table 63. GamaMabs Pharma SA Recent Developments/Updates
    Table 64. Hanmi Pharmaceuticals Co Ltd Corporation Information
    Table 65. Hanmi Pharmaceuticals Co Ltd Description and Business Overview
    Table 66. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 67. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product
    Table 68. Hanmi Pharmaceuticals Co Ltd Recent Developments/Updates
    Table 69. Jiangsu Kanion Pharmaceutical Co Ltd Corporation Information
    Table 70. Jiangsu Kanion Pharmaceutical Co Ltd Description and Business Overview
    Table 71. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 72. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product
    Table 73. Jiangsu Kanion Pharmaceutical Co Ltd Recent Developments/Updates
    Table 74. Minerva Neurosciences Inc Corporation Information
    Table 75. Minerva Neurosciences Inc Description and Business Overview
    Table 76. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 77. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase ERBB 4 Product
    Table 78. Minerva Neurosciences Inc Recent Developments/Updates
    Table 79. Pfizer Inc Corporation Information
    Table 80. Pfizer Inc Description and Business Overview
    Table 81. Pfizer Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 82. Pfizer Inc Receptor Tyrosine Protein Kinase ERBB 4 Product
    Table 83. Pfizer Inc Recent Developments/Updates
    Table 84. Puma Biotechnology Inc Corporation Information
    Table 85. Puma Biotechnology Inc Description and Business Overview
    Table 86. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 87. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase ERBB 4 Product
    Table 88. Puma Biotechnology Inc Recent Developments/Updates
    Table 89. Shanghai Fosun Pharmaceutical (Group) Co Ltd Corporation Information
    Table 90. Shanghai Fosun Pharmaceutical (Group) Co Ltd Description and Business Overview
    Table 91. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 92. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product
    Table 93. Shanghai Fosun Pharmaceutical (Group) Co Ltd Recent Developments/Updates
    Table 94. XuanZhu Pharma Co Ltd Corporation Information
    Table 95. XuanZhu Pharma Co Ltd Description and Business Overview
    Table 96. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 97. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product
    Table 98. XuanZhu Pharma Co Ltd Recent Developments/Updates
    Table 99. Zensun (Shanghai) Sci & Tech Co Ltd Corporation Information
    Table 100. Zensun (Shanghai) Sci & Tech Co Ltd Description and Business Overview
    Table 101. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 102. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product
    Table 103. Zensun (Shanghai) Sci & Tech Co Ltd Recent Developments/Updates
    Table 104. Production Base and Market Concentration Rate of Raw Material
    Table 105. Key Suppliers of Raw Materials
    Table 106. Receptor Tyrosine Protein Kinase ERBB 4 Distributors List
    Table 107. Receptor Tyrosine Protein Kinase ERBB 4 Customers List
    Table 108. Receptor Tyrosine Protein Kinase ERBB 4 Market Trends
    Table 109. Receptor Tyrosine Protein Kinase ERBB 4 Market Drivers
    Table 110. Receptor Tyrosine Protein Kinase ERBB 4 Market Challenges
    Table 111. Receptor Tyrosine Protein Kinase ERBB 4 Market Restraints
    Table 112. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 113. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share Forecast by Type (2023-2028)
    Table 114. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 115. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share Forecast by Type (2023-2028)
    Table 116. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 117. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share Forecast by Application (2023-2028)
    Table 118. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 119. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share Forecast by Application (2023-2028)
    Table 120. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 121. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share Forecast by Region (2023-2028)
    Table 122. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 123. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share Forecast by Region (2023-2028)
    Table 124. Research Programs/Design for This Report
    Table 125. Key Data Information from Secondary Sources
    Table 126. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Receptor Tyrosine Protein Kinase ERBB 4
    Figure 2. Global Receptor Tyrosine Protein Kinase ERBB 4 Market Share by Type in 2021 & 2028
    Figure 3. PB-357 Product Picture
    Figure 4. NT-113 Product Picture
    Figure 5. NRG-4 Product Picture
    Figure 6. MIN-301 Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Receptor Tyrosine Protein Kinase ERBB 4 Market Share by Application in 2021 & 2028
    Figure 9. Skin Cancer
    Figure 10. Systolic Heart Failure
    Figure 11. Neuroblastoma
    Figure 12. Oligodendroglioma
    Figure 13. Others
    Figure 14. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size (2017-2028) & (US$ Million)
    Figure 16. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales (2017-2028) & (K Pcs)
    Figure 17. Receptor Tyrosine Protein Kinase ERBB 4 Sales Share by Manufacturers in 2021
    Figure 18. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Manufacturers in 2021
    Figure 19. The Global 5 and 10 Largest Receptor Tyrosine Protein Kinase ERBB 4 Players: Market Share by Revenue in 2021
    Figure 20. Receptor Tyrosine Protein Kinase ERBB 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 21. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Region (2017-2022)
    Figure 22. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Region in 2021
    Figure 23. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Region (2017-2022)
    Figure 24. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Region in 2021
    Figure 25. U.S. Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Canada Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Germany Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. France Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. U.K. Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Italy Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Russia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. China Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Japan Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. South Korea Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. India Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Australia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Taiwan Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Indonesia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Thailand Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Malaysia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Philippines Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Vietnam Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Mexico Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Brazil Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Argentina Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Turkey Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. Saudi Arabia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 48. UAE Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 49. Sales Market Share of Receptor Tyrosine Protein Kinase ERBB 4 by Type (2017-2022)
    Figure 50. Manufacturing Cost Structure of Receptor Tyrosine Protein Kinase ERBB 4
    Figure 51. Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase ERBB 4
    Figure 52. Receptor Tyrosine Protein Kinase ERBB 4 Industrial Chain Analysis
    Figure 53. Channels of Distribution
    Figure 54. Distributors Profiles
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Aslan Pharmaceuticals Pte Ltd
Boehringer Ingelheim GmbH
GamaMabs Pharma SA
Hanmi Pharmaceuticals Co Ltd
Jiangsu Kanion Pharmaceutical Co Ltd
Minerva Neurosciences Inc
Pfizer Inc
Puma Biotechnology Inc
Shanghai Fosun Pharmaceutical (Group) Co Ltd
XuanZhu Pharma Co Ltd
Zensun (Shanghai) Sci & Tech Co Ltd
Frequently Asked Questions
Receptor Tyrosine Protein Kinase ERBB 4 report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Receptor Tyrosine Protein Kinase ERBB 4 report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Receptor Tyrosine Protein Kinase ERBB 4 report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports